Jeraygo 12.5 mg
Jeraygo 12.5 mg is a medicine authorised by Swissmedic under authorisation number 70047. The authorisation holder is Idorsia Pharmaceuticals Ltd. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 18 September 2025 and the authorisation is limited until 17 September 2030. ATC code C02KN01 places the medicine in the group Antihypertensives.
| Authorisation number | 70047 |
|---|---|
| Name | Jeraygo 12.5 mg |
| Full name | Jeraygo 12.5 mg, Filmtabletten |
| Authorisation holder | Idorsia Pharmaceuticals Ltd |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | C02KN01 |
| First authorisation | 18 September 2025 |
| Authorisation validity | 17 September 2030 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Jeraygo 12.5 mg, Filmtabletten | B | 18 September 2025 |
| 2 | Jeraygo 25 mg, Filmtabletten | B | 18 September 2025 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 30 | Tablette(n) | C02KN01 | 02.07.1. | B |
| 2 | 10 x 1 | Tablette(n) | C02KN01 | 02.07.1. | B |
| 3 | 30 | Tablette(n) | C02KN01 | 02.07.1. | B |
| 4 | 10 x 1 | Tablette(n) | C02KN01 | 02.07.1. | B |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Jeraygo 12.5 mg authorised in Switzerland?
Yes. Jeraygo 12.5 mg is authorised by Swissmedic under authorisation number 70047, data as of 01 September 2026. The authorisation is limited until 17 September 2030.
Which dispensing category does Jeraygo 12.5 mg have?
Jeraygo 12.5 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Jeraygo 12.5 mg?
The authorisation holder is Idorsia Pharmaceuticals Ltd. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.